Call Us Free: (800) 394-2767

After record IPO, Bay Area biotech CEO targets growth — and sleep


Unlike most biotech IPOs, 10X Genomics already has nine-figure revenue, and CEO Serge Saxonov says thee’s more to come.


Source link